美国严重慢性瘙痒的高未满足需求:来自执业社区皮肤科医生的调查结果

Stuart Sedlack, G. Yosipovitch, Matthew B. Kerby, Paul C Nagle, S. Ständer
{"title":"美国严重慢性瘙痒的高未满足需求:来自执业社区皮肤科医生的调查结果","authors":"Stuart Sedlack, G. Yosipovitch, Matthew B. Kerby, Paul C Nagle, S. Ständer","doi":"10.1097/itx.0000000000000018","DOIUrl":null,"url":null,"abstract":"Introduction: Chronic pruritus (CP) is a symptom of many diseases, but there is a scarcity of data on this condition in the US. Methods: We surveyed practicing, community-based US dermatologists about aspects of CP, including the number of patients seen annually, patient characteristics, treatments, and level of unmet need. US dermatologists who responded to a screening survey and reported managing ≥10 patients with CP per year were administered a 55-question web-based survey. The survey was conducted from March 27 to April 10, 2015. Results: A total of 212 survey responses were included in the analysis. The prevalence of CP in the dermatologists’ practices in the previous year was reported as 4.8%. Of 9 dermatologic conditions in the survey, CP was rated as having the highest level of unmet need (8.6 on a 10-point scale). Respondents reported that 32.7% of their patients had CP classified as severe/very severe, with 53.7% of patients having CP lasting for >1 year. Most dermatologists prescribed antihistamines (77.5%) or corticosteroids (76.1%) as first-line therapy to their patients with severe/very severe CP, and 36.3% of their patients did not respond to currently available treatments. Discussion: The combined prevalence of CP and its high level of unmet need necessitate the development of effective/tolerable treatments for this patient population.","PeriodicalId":73523,"journal":{"name":"Itch (Philadelphia, Pa.)","volume":"3 1","pages":"e18"},"PeriodicalIF":0.0000,"publicationDate":"2018-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/itx.0000000000000018","citationCount":"1","resultStr":"{\"title\":\"High unmet need in severe chronic pruritus in the United States: results from a survey of practicing community dermatologists\",\"authors\":\"Stuart Sedlack, G. Yosipovitch, Matthew B. Kerby, Paul C Nagle, S. Ständer\",\"doi\":\"10.1097/itx.0000000000000018\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Introduction: Chronic pruritus (CP) is a symptom of many diseases, but there is a scarcity of data on this condition in the US. Methods: We surveyed practicing, community-based US dermatologists about aspects of CP, including the number of patients seen annually, patient characteristics, treatments, and level of unmet need. US dermatologists who responded to a screening survey and reported managing ≥10 patients with CP per year were administered a 55-question web-based survey. The survey was conducted from March 27 to April 10, 2015. Results: A total of 212 survey responses were included in the analysis. The prevalence of CP in the dermatologists’ practices in the previous year was reported as 4.8%. Of 9 dermatologic conditions in the survey, CP was rated as having the highest level of unmet need (8.6 on a 10-point scale). Respondents reported that 32.7% of their patients had CP classified as severe/very severe, with 53.7% of patients having CP lasting for >1 year. Most dermatologists prescribed antihistamines (77.5%) or corticosteroids (76.1%) as first-line therapy to their patients with severe/very severe CP, and 36.3% of their patients did not respond to currently available treatments. Discussion: The combined prevalence of CP and its high level of unmet need necessitate the development of effective/tolerable treatments for this patient population.\",\"PeriodicalId\":73523,\"journal\":{\"name\":\"Itch (Philadelphia, Pa.)\",\"volume\":\"3 1\",\"pages\":\"e18\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1097/itx.0000000000000018\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Itch (Philadelphia, Pa.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1097/itx.0000000000000018\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Itch (Philadelphia, Pa.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/itx.0000000000000018","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

慢性瘙痒症(CP)是许多疾病的症状,但在美国缺乏关于这种情况的数据。方法:我们调查了以社区为基础的美国皮肤科医生关于CP的各个方面,包括每年就诊的患者数量、患者特征、治疗方法和未满足需求的水平。参与筛查调查并报告每年管理≥10例CP患者的美国皮肤科医生接受了一项包含55个问题的网络调查。该调查于2015年3月27日至4月10日进行。结果:共有212份调查问卷被纳入分析。据报道,前一年皮肤科医生的CP患病率为4.8%。在调查中的9种皮肤病中,CP被评为未满足需求的最高水平(10分制8.6分)。受访者报告32.7%的患者CP分为严重/非常严重,53.7%的患者CP持续100年。大多数皮肤科医生将抗组胺药(77.5%)或皮质类固醇(76.1%)作为严重/极严重CP患者的一线治疗,36.3%的患者对目前的治疗没有反应。讨论:CP的综合患病率及其未满足的高水平需要为该患者群体开发有效/耐受的治疗方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
High unmet need in severe chronic pruritus in the United States: results from a survey of practicing community dermatologists
Introduction: Chronic pruritus (CP) is a symptom of many diseases, but there is a scarcity of data on this condition in the US. Methods: We surveyed practicing, community-based US dermatologists about aspects of CP, including the number of patients seen annually, patient characteristics, treatments, and level of unmet need. US dermatologists who responded to a screening survey and reported managing ≥10 patients with CP per year were administered a 55-question web-based survey. The survey was conducted from March 27 to April 10, 2015. Results: A total of 212 survey responses were included in the analysis. The prevalence of CP in the dermatologists’ practices in the previous year was reported as 4.8%. Of 9 dermatologic conditions in the survey, CP was rated as having the highest level of unmet need (8.6 on a 10-point scale). Respondents reported that 32.7% of their patients had CP classified as severe/very severe, with 53.7% of patients having CP lasting for >1 year. Most dermatologists prescribed antihistamines (77.5%) or corticosteroids (76.1%) as first-line therapy to their patients with severe/very severe CP, and 36.3% of their patients did not respond to currently available treatments. Discussion: The combined prevalence of CP and its high level of unmet need necessitate the development of effective/tolerable treatments for this patient population.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Real-world clinical efficacy of nemolizumab in Japanese patients with atopic dermatitis Kappa opioid agonists in the treatment of itch: just scratching the surface? Oral administration of 4′-demethyl nobiletin inhibits dry skin-induced mechanical alloknesis The effect of repetitive topical applications of local anesthetics (EMLA) on experimental pain and itch (histaminergic and nonhistaminergic) Potential antipruritic neuronal targets of nalfurafine in the murine spinal dorsal horn
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1